Gilla Kaplan sold Tyra Biosciences ($TYRA) shares on the open market five times in the last year, totaling $628 thousand. Her most recent sale occurred on June 18, 2025. These sales rank her 5,985th among 11,678 insiders by value sold, below the average of 8.6 million per insider across 6.4 transactions. Kaplan made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 28, 2026 | Avalo Therapeutics, Inc. | $AVTX | KAPLAN GILLA | Not found | M | Restricted Stock Units | 3166 | $0.00 | 3,167.0000 | 18,133,968 | 49.99% | 0.02% |
| March 28, 2026 | Avalo Therapeutics, Inc. | $AVTX | KAPLAN GILLA | Not found | M | Common Stock | 3166 | $0.00 | 6,333.0000 | 18,133,968 | 99.97% | 0.02% |
| March 26, 2026 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | M | Stock Option (Right to Buy) | 53172 | $0.00 | 0.0000 | 59,670,757 | 100.00% | 0.09% |
| March 25, 2026 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | M | Stock Option (Right to Buy) | 14295 | $0.00 | 53,172.0000 | 59,670,757 | 21.19% | 0.02% |
| March 26, 2026 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | D | Common Stock | 53172 | $37.75 | 28,231.0000 | 59,670,757 | 65.32% | 0.09% |
| March 25, 2026 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | S | Common Stock | 14295 | $36.97 | 28,231.0000 | 59,670,757 | 33.61% | 0.02% |
| March 26, 2026 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | M | Common Stock | 53172 | $2.25 | 81,403.0000 | 59,670,757 | 39.51% | 0.09% |
| March 25, 2026 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | M | Common Stock | 14295 | $2.25 | 42,526.0000 | 59,670,757 | 50.64% | 0.02% |
| June 17, 2025 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | S | Common Stock | 10 | $10.35 | 37,799.0000 | 57,217,746 | 0.03% | 0.00% |
| June 18, 2025 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | S | Common Stock | 9568 | $9.78 | 28,231.0000 | 57,217,746 | 25.31% | 0.02% |
| June 17, 2025 | Avalo Therapeutics, Inc. | $AVTX | KAPLAN GILLA | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| June 12, 2025 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | S | Common Stock | 30000 | $10.31 | 59,623.0000 | 57,217,746 | 33.47% | 0.05% |
| June 13, 2025 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | S | Common Stock | 15000 | $10.31 | 44,623.0000 | 57,217,746 | 25.16% | 0.03% |
| June 16, 2025 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | S | Common Stock | 6814 | $10.38 | 37,809.0000 | 57,217,746 | 15.27% | 0.01% |
| May 29, 2025 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | A | Stock Option (Right to Buy) | 22200 | $0.00 | 22,200.0000 | 57,217,746 | 9999.99% | 0.04% |
| March 28, 2025 | Avalo Therapeutics, Inc. | $AVTX | KAPLAN GILLA | Director | M | Common Stock | 3167 | $0.00 | 3,167.0000 | 10,671,934 | 9999.99% | 0.03% |
| March 28, 2025 | Avalo Therapeutics, Inc. | $AVTX | KAPLAN GILLA | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| Aug. 13, 2024 | Avalo Therapeutics, Inc. | $AVTX | KAPLAN GILLA | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Avalo Therapeutics, Inc. | $AVTX | KAPLAN GILLA | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | M | Stock Option (Right to Buy) | 61392 | $0.00 | 0.0000 | 42,704,876 | 100.00% | 0.14% |
| June 13, 2024 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | M | Common Stock | 61392 | $0.61 | 89,623.0000 | 42,704,876 | 217.46% | 0.14% |
| May 29, 2024 | Tyra Biosciences, Inc. | $TYRA | KAPLAN GILLA | Not found | A | Stock Option (Right to Buy) | 18600 | $0.00 | 18,600.0000 | 42,704,876 | 9999.99% | 0.04% |
| Dec. 20, 2023 | Avalo Therapeutics, Inc. | $AVTX | KAPLAN GILLA | Director | A | Stock Option (Right to Buy) | 3334 | $0.00 | 3,334.0000 | 0 | 9999.99% | 0.00% |